NP/PA Connect
News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
More
Publication
Dermatology Times
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • NP/PA Connect
  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Non-Melanoma Skin Cancers
  • Vitiligo
  • Wound Care
Advertisement

Nicholas Golda, MD, FACMS

Advertisement

Articles by Nicholas Golda, MD, FACMS

Nicholas Golda, MD Shares Pearls to Manage Bleeding in Mohs Surgery

ByLauren Buchanan, MA, Managing Editor,Nicholas Golda, MD, FACMS
May 6th 2023

Golda explains why he prefers using tranexamic acid to control bleeding in granulated wounds.

Advertisement

Latest Updated Articles

  • Nicholas Golda, MD Shares Pearls to Manage Bleeding in Mohs Surgery
    Nicholas Golda, MD Shares Pearls to Manage Bleeding in Mohs Surgery

    Published: May 6th 2023 | Updated:



Advertisement
Advertisement

Trending on Dermatology Times

1

Delgocitinib Advances to Phase 3 Evaluation for Lichen Sclerosus

2

The Aesthetic Edge: January 2026

3

Case-Based Perspectives on Biologic Treatment for Hidradenitis Suppurativa

4

LEVEL UP Study Shows Benefits of Switching From Dupilumab to Upadacitinib in AD

5

Atopia Therapeutics Reports Positive Preclinical Data for ATP-R13 as Disease-Modifying Oral AD Therapy

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us